COMPOSITION FOR TREATMENT OF JOINT DISEASE

摘要

The specification discloses the use of a low endotoxin monovalent metal salt of alginic acid in the manufacture of a medicament for the inhibition of degeneration of synovial tissue in rheumatoid arthritis, for the inhibition of joint destruction in rheumatoid arthritis or for the treatment of rheumatoid arthritis, wherein the medicament is to be injected into a joint; and preferably the medicament does not contain a curing agent of a monovalent metal salt of alginic acid, and it also does not contain cells for cartilage tissue regeneration.